---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-100727"
form_type: "8-K"
ticker: "ADGM"
cik: "0002006986"
company_name: "Adagio Medical Holdings, Inc."
filed_at: "2025-10-20T23:59:59+00:00"
generated_at: "2026-05-17T03:18:33.755545+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Adagio Medical closes $19M private placement to fund VT ablation device and FDA submission

## Summary
- Closed $19M upfront private placement led by existing and new healthcare institutional investors.
- Proceeds to support FULCRUM-VT pivotal study PMA submission for vCLAS ULTC System and next-gen catheter.
- Will expand manufacturing, scale commercial-readiness, and extend cash runway into key inflection points.
- Over 350 patients treated across regulatory studies, commercial, and compassionate use.
- CEO states financing de-risks execution and provides flexibility to advance ULTC therapies for VT.

## SEC filing metadata
- accession: 0001104659-25-100727
- form_type: 8-K
- ticker: ADGM
- cik: 0002006986
- company_name: Adagio Medical Holdings, Inc.
- filed_at: 2025-10-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2006986/000110465925100727/0001104659-25-100727-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2006986/000110465925100727/tm2529093d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-100727
- JSON: https://secwatch.observer/filing/0001104659-25-100727.json
- Plain text: https://secwatch.observer/filing/0001104659-25-100727.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.